The epidemiology of Chagas disease in the Americas
- PMID: 39474465
- PMCID: PMC11519694
- DOI: 10.1016/j.lana.2024.100881
The epidemiology of Chagas disease in the Americas
Abstract
Chagas disease is a complex parasitic zoonosis that still threatens public health across the Americas. Initiatives to control Trypanosoma cruzi transmission via blood transfusion and non-native triatomine-bug vectors have yielded crucial advances; native vectors, however, actively bridge wild and domestic/peri-domestic transmission cycles throughout the region, and tens of thousands of people become infected each year. Oral-transmission outbreaks, urbanisation, and vertical transmission are additional/emerging issues calling for innovative strategic thinking. While critical for advocacy and sustained public health action, assessing Chagas disease burden remains difficult; the often-asymptomatic nature of T. cruzi infection, healthcare access limitations, pervasive underreporting, and other methodological hurdles inherent to reliably measuring incidence, prevalence, and disease progression all contribute to the difficulty. Whether and how parasite, vector, and host genetic makeups affect transmission dynamics and epidemiology is also unclear. Continued high-quality research and long-term, adaptive strategies combining vector control surveillance with enhanced case detection and integral patient care remain critical to effectively address the ethical and societal challenge of Chagas disease control. This is the first in a Series of five papers about Chagas Disease. All papers in the Series are available at https://www.thelancet.com/series/chagasdisease.
Keywords: Chagas disease; Control; Disease burden; Transmission; Trypanosoma cruzi.
© 2024 The Authors.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission.Mem Inst Oswaldo Cruz. 2022 Jul 6;117:e210130. doi: 10.1590/0074-02760210130. eCollection 2022. Mem Inst Oswaldo Cruz. 2022. PMID: 35830010 Free PMC article.
-
Modeling the impact of xenointoxication in dogs to halt Trypanosoma cruzi transmission.medRxiv [Preprint]. 2023 Jan 25:2023.01.24.23284917. doi: 10.1101/2023.01.24.23284917. medRxiv. 2023. Update in: PLoS Comput Biol. 2023 May 8;19(5):e1011115. doi: 10.1371/journal.pcbi.1011115. PMID: 36747723 Free PMC article. Updated. Preprint.
-
Chagas Disease Ecology in the United States: Recent Advances in Understanding Trypanosoma cruzi Transmission Among Triatomines, Wildlife, and Domestic Animals and a Quantitative Synthesis of Vector-Host Interactions.Annu Rev Anim Biosci. 2022 Feb 15;10:325-348. doi: 10.1146/annurev-animal-013120-043949. Epub 2021 Nov 10. Annu Rev Anim Biosci. 2022. PMID: 34758274 Review.
-
Genotyping of Trypanosoma cruzi in a hyper-endemic area of Colombia reveals an overlap among domestic and sylvatic cycles of Chagas disease.Parasit Vectors. 2014 Mar 21;7:108. doi: 10.1186/1756-3305-7-108. Parasit Vectors. 2014. PMID: 24656115 Free PMC article.
-
What makes an effective Chagas disease vector? Factors underlying Trypanosoma cruzi-triatomine interactions.Acta Trop. 2018 Jul;183:23-31. doi: 10.1016/j.actatropica.2018.04.008. Epub 2018 Apr 3. Acta Trop. 2018. PMID: 29625091 Review.
Cited by
-
Discovery and Early Optimization of 1H-Indole-2-carboxamides with Anti-Trypanosoma cruzi Activity.J Med Chem. 2025 Apr 10;68(7):7313-7340. doi: 10.1021/acs.jmedchem.4c02942. Epub 2025 Mar 31. J Med Chem. 2025. PMID: 40163677 Free PMC article.
-
Epidemiology of Chagas Disease in the United States of America: A Short Review and Some Comments.Pathogens. 2025 Jan 1;14(1):24. doi: 10.3390/pathogens14010024. Pathogens. 2025. PMID: 39860985 Free PMC article. Review.
-
Fighting Strategies Against Chagas' Disease: A Review.Pathogens. 2025 Feb 12;14(2):183. doi: 10.3390/pathogens14020183. Pathogens. 2025. PMID: 40005558 Free PMC article. Review.
-
Untargeted Metabolomics of Epimastigote Forms of Trypanosoma cruzi.Bio Protoc. 2025 Jul 5;15(13):e5368. doi: 10.21769/BioProtoc.5368. eCollection 2025 Jul 5. Bio Protoc. 2025. PMID: 40655427 Free PMC article.
-
Inhibitory Activity of Compounds Obtained from Streptomyces Against Trypanosoma cruzi.Pathogens. 2025 Jun 26;14(7):638. doi: 10.3390/pathogens14070638. Pathogens. 2025. PMID: 40732686 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources